When was GATEWAY BIOTECHNOLOGY, INC. founded?

GATEWAY BIOTECHNOLOGY, INC. was founded in 2016.

Where is GATEWAY BIOTECHNOLOGY, INC. headquartered?

GATEWAY BIOTECHNOLOGY, INC. is headquartered in SAINT LOUIS, Missouri, United States.

What industry is GATEWAY BIOTECHNOLOGY, INC. in?

GATEWAY BIOTECHNOLOGY, INC. operates in Biotech, Healthcare.

How many employees does GATEWAY BIOTECHNOLOGY, INC. have?

GATEWAY BIOTECHNOLOGY, INC. has 1-10 employees.

GATEWAY BIOTECHNOLOGY, INC.

Developing First-in-Class Drug Therapies for Hearing Disorders

SAINT LOUIS, United States · Founded 2016

Biotech

Healthcare

Headquarters: SAINT LOUIS, Missouri
Employees: 1–10
Founded: 2016

Business Model: B2G
Website: gtwbio.com
Last Round: Convertible NoteJun 2025

About

Gateway Biotechnology is developing first-in-class small molecule and gene therapy-based treatments for hearing disorders including noise-induced hearing loss and tinnitus. Funded by NIH and the Department of Defense, the company has 7 SBIR/STTR grants, 2 patents, and 5 published papers, with its lead product undergoing a Phase II clinical trial under an exclusive U.S. Army contract.

Summary

GATEWAY BIOTECHNOLOGY, INC. is a Biotech company based in SAINT LOUIS, United States, founded in 2016. Its most recent funding was a Convertible Note round in Jun 2025.

LinkedIn X (Twitter)